OMX Nordic 40
2 298,46
|
5,44
|
0,24 %
|
Analysen zu OMX Nordic 40-Werten
01.07.25 | AstraZeneca Buy | UBS AG | |
30.06.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
30.06.25 | Novo Nordisk Buy | UBS AG | |
27.06.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
27.06.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
26.06.25 | Hennes & Mauritz AB Neutral | UBS AG | |
26.06.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
26.06.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
26.06.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
26.06.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
26.06.25 | AstraZeneca Outperform | Bernstein Research | |
25.06.25 | ABB Sell | Deutsche Bank AG | |
25.06.25 | Volvo AB Buy | UBS AG | |
24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.06.25 | Volvo AB Underperform | Bernstein Research | |
24.06.25 | Volvo AB Buy | UBS AG | |
24.06.25 | Novo Nordisk Buy | UBS AG | |
24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
23.06.25 | ABB Underperform | Bernstein Research | |
23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.06.25 | Novo Nordisk Buy | UBS AG | |
18.06.25 | Volvo AB Underperform | Bernstein Research | |
17.06.25 | Novo Nordisk Buy | UBS AG | |
16.06.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.06.25 | Novo Nordisk Buy | UBS AG | |
13.06.25 | ABB Underperform | Bernstein Research | |
12.06.25 | Volvo AB Underperform | Bernstein Research | |
12.06.25 | Novo Nordisk Market-Perform | Bernstein Research | |
11.06.25 | Volvo AB Underperform | Bernstein Research | |
10.06.25 | ABB Underperform | Bernstein Research | |
10.06.25 | Volvo AB Buy | Deutsche Bank AG | |
10.06.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
09.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
06.06.25 | Novo Nordisk Buy | Deutsche Bank AG |